Cargando…

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1

Lines of evidence have demonstrated that the oncogenic miRNAs are pivotal to the progression of breast cancer. In this study, we investigated the biological traits of microRNA-429 (miR-429) in triple-negative breast cancer (TNBC) and the underlying molecular mechanism. We found that miR-429 was nota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yao, Meng, Xue, Luo, Yuqing, Luo, Shuai, Li, Jin, Zeng, Jiafei, Huang, Xiang, Wang, Jinjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564445/ https://www.ncbi.nlm.nih.gov/pubmed/37737712 http://dx.doi.org/10.18632/aging.205051

Ejemplares similares

miR-429 promotes the proliferation of non-small cell lung cancer cells via targeting DLC-1
por: Xiao, Peng, et al.
Publicado: (2021)

Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer
por: Liu, Hong, et al.
Publicado: (2016)

MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1
por: Deng, Yi, et al.
Publicado: (2017)

LncRNA PCAT19 induced by SP1 and acted as oncogene in gastric cancer competitively binding to miR429 and upregulating DHX9
por: Xiao, Lei, et al.
Publicado: (2022)

miR-429 Inhibits Differentiation and Promotes Proliferation in Porcine Preadipocytes
por: Peng, Ying, et al.
Publicado: (2016)

Theranostic application of miR-429 in HER2+ breast cancer
por: Cava, Claudia, et al.
Publicado: (2020)

MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2
por: Chen, Xia, et al.
Publicado: (2020)

miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1
por: Wang, Zhihui, et al.
Publicado: (2019)

miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
por: Dai, Wenzhu, et al.
Publicado: (2019)

Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
por: Zhou, Xueliang, et al.
Publicado: (2020)

miR-429 inhibits migration and invasion of breast cancer cells in vitro
por: YE, ZHI-BIN, et al.
Publicado: (2014)

Modulation of miR-429 during osmotic stress in the silverside Odontesthes humensis
por: Pagano, Antônio D., et al.
Publicado: (2022)

Oncogenic Role of miR-200c-3p in High-Grade Serous Ovarian Cancer Progression via Targeting the 3′-Untranslated Region of DLC1
por: Ankasha, Sheril June, et al.
Publicado: (2021)

miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22
por: Li, Xiaodong, et al.
Publicado: (2017)

miR-429-3p/LPIN1 Axis Promotes Chicken Abdominal Fat Deposition via PPARγ Pathway
por: Chao, Xiaohuan, et al.
Publicado: (2020)

Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer
por: Zhu, Wangyu, et al.
Publicado: (2014)

MiR-429 Inhibits Oral Squamous Cell Carcinoma Growth by Targeting ZEB1
por: Lei, Wanke, et al.
Publicado: (2015)

Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR-429
por: Gu, Yongjuan, et al.
Publicado: (2021)

Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical Cancer
por: Shukla, Vaibhav, et al.
Publicado: (2023)

miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53
por: Lee, Kyung-Jun, et al.
Publicado: (2023)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Postoperative recurrence of mixed extragonadal germ cell tumor in the right shoulder: a case report
por: Li, Yao, et al.
Publicado: (2023)

Next-Generation Sequencing Analysis of 3 Uterine Adenosarcomas with Heterogeneously Differentiated Genomic Mutations
por: Li, Yao, et al.
Publicado: (2023)

IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer
por: Cui, Hengmi, et al.
Publicado: (2016)

MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis
por: Wong, Chun-Ming, et al.
Publicado: (2015)

EPDR1, Which Is Negatively Regulated by miR-429, Suppresses Epithelial Ovarian Cancer Progression via PI3K/AKT Signaling Pathway
por: Zhao, Zhendan, et al.
Publicado: (2021)

Angiogenesis Driven by the CEBPD–hsa-miR-429–VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression
por: Chan, Ti-Chun, et al.
Publicado: (2022)

Oncogenic miR-9 is a target of erlotinib in NSCLCs
por: Chen, Xi, et al.
Publicado: (2015)

Long noncoding RNA HEIH promotes melanoma cell proliferation, migration and invasion via inhibition of miR-200b/a/429
por: Zhao, Haiying, et al.
Publicado: (2017)

A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
por: Guo, Chunmei, et al.
Publicado: (2020)

miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells
por: Zhang, Min, et al.
Publicado: (2016)

MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer
por: Wu, Chia-Lun, et al.
Publicado: (2016)

Linc00641 promotes the progression of gastric carcinoma by modulating the miR-429/Notch-1 axis
por: Hang, Qun, et al.
Publicado: (2021)

Knockdown of USF1 Inhibits the Vasculogenic Mimicry of Glioma Cells via Stimulating SNHG16/miR-212-3p and linc00667/miR-429 Axis
por: Wang, Di, et al.
Publicado: (2019)

DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016)

Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses
por: Xiao, Xiao, et al.
Publicado: (2021)

The Clinical Significance of MiR-429 as a Predictive Biomarker in Colorectal Cancer Patients Receiving 5-Fluorouracil Treatment
por: Dong, Sheng-jian, et al.
Publicado: (2016)

MiR‐429 suppresses proliferation and invasion of breast cancer via inhibiting the Wnt/β‐catenin signaling pathway
por: Zhang, Liping, et al.
Publicado: (2020)

PART1 and hsa-miR-429-Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients
por: Xuan, Chengmin, et al.
Publicado: (2020)

Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma
por: Chen, Xiangjun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q8jhd8ndpm18c4l00gspmge7ar